Lilly's cancer drug more effective than AbbVie's in head-to-head study - Reuters

Reuters | July 29, 2025, 7:14 a.m. | Original
Lilly's cancer drug more effective than AbbVie's in head-to-head study Reuters
Duke Energy to sell Tennessee natural gas business to Spire for $2.48 billion - Reuters Union Pacific to buy Norfolk in $85 billion mega US railroad deal - Reuters